Back
Bristol-Myers Squibb Co (BMY)
PharmaceuticalsBMY · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$67.93
+0.94%Weekly undervalued picks (like BMY)
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$3.46
ROE
38.7%
Gross margin
72.0%
Debt/Equity
2.31x
Revenue growth
2.6%
Bristol-Myers Squibb Co — company intelligence
Earnings surprises
Q2 2026$2.04 vs $1.60 est+27.2%
Q1 2026$1.58 vs $1.43 est+10.4%
Q4 2025$1.26 vs $1.13 est+11.9%
Q3 2025$1.63 vs $1.52 est+6.9%
Analyst consensus · 35 analysts
14 Buy19 Hold2 Sell
Updated Aug 23, 2026
Insider activity · 90 days
5 buys3 sellsnet -27,211 shares
Massacesi CristianSell 26,175 · Aug 1, 2026
Gallman CariSell 543 · Aug 1, 2026
Gallman Cariother 1,061 · Aug 1, 2026
Recent SEC filings
4 — Insider transaction reportAug 4, 2026
4 — Insider transaction reportAug 4, 2026
10-Q — Quarterly reportJul 30, 2026
Latest news
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields — Benzinga · 23h ago
Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK — Yahoo · 4d ago
Can Eliquis Cushion Bristol Myers' Legacy Portfolio Erosion? — Yahoo · 4d ago
JANX Shares Gain 19.1% in 3 Months: Here's What You Need to Know — Yahoo · 4d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks (like BMY)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.